Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026)

Updated

Xeris Biopharma Holdings' EV to EBITDA came in at 23.98 for Q2 2026, down 80.9% from 125.39 a year earlier but up 38.8% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported EV to EBITDA of 17.96, down 79.9% year-over-year; for FY2025, it came in at 29.51.

  • The five-year range for quarterly EV to EBITDA is 17.27 (Q1 2026) to 125.39 (Q2 2025).
  • Business Quant data shows XERS's EV to EBITDA at 17.27 (Q1 2026), 29.56 (Q4 2025) and 49.86 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 25.83
Jun 30, 2026 24.00
Mar 31, 2026 17.29
Dec 31, 2025 29.60
Sep 30, 2025 49.93
Jun 30, 2025 125.39
API Access

Xeris Biopharma Holdings EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=XERS&period=max&api_key=YOUR_API_KEY